{
    "2021-06-24": [
        [
            {
                "time": "",
                "original_text": "万泰生物：收到与GSK合作的第二个里程碑款项8468.24万元",
                "features": {
                    "keywords": [
                        "万泰生物",
                        "GSK",
                        "合作",
                        "里程碑款项",
                        "8468.24万元"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "万泰生物(603392.SH)：收到与GSK合作的第二个里程碑款项8468.24万元",
                "features": {
                    "keywords": [
                        "万泰生物",
                        "603392.SH",
                        "GSK",
                        "合作",
                        "里程碑款项",
                        "8468.24万元"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            }
        ]
    ]
}